PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Some patients may need only a lumpectomy, removing the cancer and a margin of surrounding tissue. Others may undergo a mastectomy, removing most or all breast tissue. Surgery may also involve sampling lymph nodes, removing additional lymph nodes, or reconstructing the breast.
And an important point sometimes gets lost in the anxiety surrounding a cancer diagnosis:
More extensive surgery does not necessarily mean better survival.
For many patients with early-stage breast cancer who are appropriate candidates, decades of randomized clinical evidence show that breast-conserving treatment can provide long-term survival comparable to mastectomy.
The goal should therefore be not simply to “get everything out,” but to choose the operation that provides adequate cancer control while minimizing unnecessary long-term side effects.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer surgery.
Good luck,
Possible Breast Cancer Therapies
There are several basic approaches.
| Surgery | What Is Removed | Common Situation |
|---|---|---|
| Lumpectomy / breast-conserving surgery | Tumor plus surrounding margin of normal tissue | Many early-stage breast cancers |
| Mastectomy | Nearly all breast tissue | Larger tumors, multicentric disease, certain genetic risks, patient preference |
| Sentinel lymph node biopsy (SLNB) | One or several first-draining lymph nodes | Used to determine whether invasive cancer has reached regional nodes |
| Axillary lymph node dissection (ALND) | Larger number of underarm lymph nodes | Selected patients with significant nodal involvement |
| Oncoplastic surgery | Tumor removal combined with plastic-surgery techniques | Breast conservation when a larger volume of tissue must be removed |
| Breast reconstruction | Rebuilding the breast with implants or the patient’s own tissue | May occur immediately or months/years after mastectomy |
The appropriate operation depends on much more than tumor size alone.
Factors can include:
The National Cancer Institute provides an overview of current breast cancer surgical approaches. NCI — Surgery to Treat Breast Cancer
This may be the most important question a newly diagnosed patient can ask.
For appropriately selected early-stage breast cancers:
Mastectomy has not been shown to provide a survival advantage over breast-conserving surgery followed by appropriate radiation.
Long-term randomized trials extending to approximately 20 years demonstrated comparable survival between the two approaches.
That does not mean lumpectomy is appropriate for everyone.
Mastectomy may be recommended when:
But for many women with localized breast cancer, the decision between lumpectomy and mastectomy may involve quality of life, radiation requirements, reconstruction, cosmetic outcomes and personal preference rather than survival alone.
★★★★★ Established clinical evidence
Multiple randomized trials with long-term follow-up support equivalent overall survival for appropriately selected patients receiving breast-conserving treatment versus mastectomy.
Lumpectomy is also called:
The surgeon removes the tumor along with an area of surrounding tissue.
That surrounding tissue matters because the pathologist examines the edges of the specimen—the surgical margins—to determine whether cancer cells extend to the edge.
If tumor cells remain at the margin, additional surgery may sometimes be necessary.
However, modern breast surgery has increasingly moved away from unnecessarily wide margins. The objective is adequate cancer clearance without removing more healthy breast tissue than necessary.
The American Society of Breast Surgeons provides guidance concerning surgical margins following breast-conserving surgery. ASBrS — Breast Conservation Surgery Margins
Lumpectomy removes the visible cancer, but microscopic cancer cells can remain elsewhere within the breast.
Radiation reduces the risk that breast cancer will recur locally.
A major meta-analysis of randomized trials found that radiation following breast-conserving surgery substantially reduced breast cancer recurrence and also produced a smaller long-term reduction in breast-cancer mortality.
Radiation is therefore part of breast-conserving therapy, even though it occurs separately from the operation.
There are exceptions.
Some carefully selected older patients with small, hormone-receptor-positive, node-negative tumors may discuss omitting radiation. Long-term trial results indicate that omission increases the risk of local recurrence while having little or no apparent effect on overall survival in appropriately selected populations.
This makes the question highly individualized:
What is the absolute reduction in recurrence that radiation offers me, and does it change my survival?
That question may lead to a more useful discussion than simply asking, “Do I need radiation?”
A mastectomy removes most or all breast tissue.
Several forms exist.
The breast tissue, nipple and areola are removed.
Most breast tissue is removed while preserving much of the breast skin to facilitate reconstruction.
Breast tissue is removed while the nipple, areola and breast skin may be preserved in appropriately selected patients.
The breast and a larger group of axillary lymph nodes are removed.
The old-fashioned radical mastectomy, which removed the breast, lymph nodes and chest muscles, is rarely necessary today.
This is an important distinction.
Removing the healthy opposite breast is called a contralateral prophylactic mastectomy.
It can substantially reduce the likelihood of developing a new breast cancer in that breast.
But that is different from preventing the original cancer from metastasizing elsewhere in the body.
Once invasive breast cancer exists, distant recurrence results from cancer cells originating from the original tumor—not from breast tissue remaining in the opposite breast.
Consequently, bilateral mastectomy may be appropriate for selected patients, particularly those with substantial hereditary risk, but it should not automatically be interpreted as a treatment that improves survival for every patient with cancer in one breast.
The American Society of Breast Surgeons specifically advises against routinely performing double mastectomy for cancer involving only one breast.
A useful question is:
“Will removing my healthy breast improve my survival, or will it primarily reduce my risk of developing a second breast cancer?”
Those are two very different benefits.
Breast cancer frequently spreads first through lymphatic channels to lymph nodes in the armpit.
Knowing whether cancer has reached these nodes helps determine:
Historically, surgeons routinely removed many axillary lymph nodes.
That approach caused substantial long-term complications.
Today, many patients undergo a much more limited procedure called a sentinel lymph node biopsy.
The sentinel lymph nodes are the first nodes most likely to receive lymphatic drainage from a breast tumor.
During surgery, the surgeon identifies and removes these nodes and sends them to pathology.
If the sentinel nodes are negative, more extensive lymph-node surgery can frequently be avoided.
NCI — Sentinel Lymph Node Biopsy
This represents one of the major advances in breast cancer surgery because it allows surgeons to obtain staging information while reducing unnecessary lymph-node removal.
Not necessarily.
This is another area where breast cancer surgery has become less aggressive.
Long-term clinical trial results show that selected women undergoing breast-conserving treatment who have only one or two positive sentinel lymph nodes can often avoid a complete axillary lymph node dissection without sacrificing survival.
That distinction matters because removing many axillary lymph nodes increases the risks of:
The appropriate amount of lymph-node surgery depends on tumor stage, the number and extent of positive nodes, systemic treatment, radiation plans and other factors.
★★★★★ Established clinical evidence
Selected early-stage breast cancer patients with limited sentinel-node involvement can avoid completion axillary dissection without compromising long-term survival.
One of the most important long-term risks of breast cancer surgery is lymphedema.
The lymphatic system normally drains fluid from tissue.
Removing or damaging lymph nodes can interfere with that drainage, causing swelling in the:
Radiation involving regional lymph nodes can further increase this risk.
The risk is generally greater following extensive axillary lymph-node dissection than following sentinel-node biopsy.
This is one reason avoiding unnecessary axillary surgery matters.
Patients should report:
Early assessment by a physical therapist or certified lymphedema specialist may help prevent mild symptoms from becoming more disabling.
Surgery can produce both short- and long-term effects.
| Possible Effect | What Patients May Experience |
| Pain | Incisional or chest-wall pain |
| Seroma | Fluid collection near the surgical area |
| Infection | Redness, warmth, drainage or fever |
| Numbness | Particularly around the breast, chest wall or underarm |
| Shoulder stiffness | Reduced range of motion |
| Lymphedema | Swelling of arm, hand, breast or chest |
| Scar tissue | Tightness or pulling |
| Body-image changes | Emotional adjustment following breast removal |
| Chronic post-surgical pain | Persistent nerve or musculoskeletal discomfort |
| Reconstruction complications | Implant problems, infection, flap complications or additional operations |
Cancer surgery should therefore be judged not only by whether the operation successfully removes the tumor but also by its long-term functional consequences.
Reconstruction can be performed:
Immediately — during the same operation as the mastectomy.
or
Later — after cancer treatment has been completed.
Reconstruction may involve:
There is no universally correct answer.
The decision can depend on:
A patient considering mastectomy should ideally have an opportunity to discuss reconstruction before the mastectomy, even if she ultimately chooses no reconstruction.
And reconstruction is not mandatory.
Some patients choose an aesthetic flat closure rather than reconstruction.
That is also a legitimate surgical choice.
Yes.
Some breast cancers are treated with neoadjuvant therapy, meaning drug treatment is given before surgery.
This may include:
Preoperative treatment can:
This strategy is especially important in some:
The sequence of treatment should therefore sometimes be decided before an operation is scheduled.
Ductal carcinoma in situ—DCIS—requires a somewhat different discussion.
DCIS means abnormal cells remain inside the milk ducts and have not invaded surrounding breast tissue.
It is Stage 0 disease.
Treatment may include:
But DCIS is biologically heterogeneous.
Some lesions may pose substantially greater progression risk than others.
This makes the balance between preventing future invasive breast cancer and avoiding overtreatment particularly important.
Patients diagnosed with DCIS should understand precisely:
before deciding how aggressively to treat it.
Once surgery is recommended, the time between diagnosis and operation can be used productively.
Ask specifically about:
These variables may influence whether surgery should occur first or after systemic treatment.
For many early-stage cancers, patients do.
Ask:
If not:
“What specifically makes mastectomy necessary in my case?”
A lumpectomy decision cannot always be separated from a radiation decision.
Meet with a radiation oncologist when appropriate before deciding between lumpectomy and mastectomy.
If mastectomy is being considered, reconstruction options should ideally be understood beforehand.
Lumpectomy is frequently performed as outpatient surgery.
Mastectomy may require an overnight hospital stay, although practice varies.
Depending on the operation, patients may receive:
After mastectomy, drains may remain temporarily to remove fluid while tissues heal.
Patients should receive clear instructions about:
Recovery varies substantially.
A straightforward lumpectomy may require relatively little recovery time.
A bilateral mastectomy with reconstruction can be a major operation requiring weeks of healing.
The guiding principle should be progressive recovery rather than prolonged inactivity.
When cleared by the surgical team, movement helps restore:
Physical therapy may be especially useful when patients develop:
Call your care team promptly for:
Do not assume that significant symptoms are simply “part of recovery.”
Surgery provides much more information than whether the visible tumor was removed.
The final pathology may establish:
These findings help determine what happens after surgery.
Depending on the results, additional therapy may include:
This is why breast cancer surgery should be understood as one component of a broader treatment strategy rather than an isolated procedure.
| Approach | PBC Evidence Rating | What the Evidence Supports |
| Surgery for operable localized breast cancer | ★★★★★ | Established curative treatment |
| Lumpectomy + appropriate radiation for eligible early-stage disease | ★★★★★ | Long-term survival comparable with mastectomy |
| Sentinel lymph node biopsy instead of routine axillary dissection | ★★★★★ | Established staging approach with less morbidity |
| Avoiding ALND in selected patients with 1–2 positive sentinel nodes | ★★★★★ | Strong randomized clinical evidence |
| Radiation after most breast-conserving surgery | ★★★★★ | Major reduction in local recurrence; benefit varies by individual risk |
| Radiation omission in carefully selected older, low-risk patients | ★★★★☆ | Strong evidence for selected populations; increases local recurrence but may not alter survival |
| Contralateral prophylactic mastectomy for average-risk unilateral cancer | ★★☆☆☆ for survival benefit | Reduces second-breast cancer risk but does not routinely translate into better survival |
| Exercise/physical therapy during recovery | ★★★★☆ | Supports mobility, strength and functional recovery |
| Lymphedema surveillance and early rehabilitation | ★★★★☆ | Strong supportive-care rationale and growing clinical evidence |
How to interpret the PBC rating: Five stars indicates strong clinical evidence and incorporation into established cancer care. Lower ratings do not necessarily mean a therapy is ineffective; they indicate greater uncertainty regarding clinical benefit.
Bring these questions to your appointment:
Perhaps the single most useful question is:
“What is the least extensive operation that can safely treat my cancer?”
Breast cancer surgery has changed dramatically.
The historical philosophy of removing as much breast tissue and as many lymph nodes as possible has gradually been replaced by a more individualized approach.
For many early-stage breast cancers:
Lumpectomy plus appropriate radiation can achieve survival comparable to mastectomy.
For many patients with clinically negative lymph nodes:
Sentinel lymph-node biopsy can replace extensive axillary surgery.
And even among selected patients with limited sentinel-node involvement:
Complete axillary lymph-node dissection may not be necessary.
These advances matter because breast cancer treatment is not only about surviving cancer.
It is also about limiting unnecessary treatment, maintaining arm and shoulder function, reducing lymphedema and chronic pain, preserving quality of life and making an informed treatment decision based on absolute risks and benefits.
Your goal is not to undergo the biggest operation possible.
It is to undergo the right operation for your cancer and your priorities.
National Cancer Institute
Long-Term Breast-Conservation Research
Radiation After Breast-Conserving Surgery
Surgical Guidelines
To learn more about sentinel node biopsy:
For the lymphedema discussion:
For postoperative complications:
For a broader survivorship/side-effect link:
For patients whose pathology leads to a chemotherapy discussion: